Back to LYEL
Bank of New York Mellon Corp → LYEL
Bank of New York Mellon Corp LYEL Position History
Lyell Immunopharma, Inc. • Healthcare
Quarters held
7
Latest value
$10
Q3 2026
Peak value
$219K
First seen
Q2 2026
Dollar value over time
Show data table
| Period | Position value |
|---|---|
| Q2 2026 | $128K |
| Q2 2026 | $219K |
| Q2 2026 | $14 |
| Q3 2026 | $76K |
| Q3 2026 | $166K |
| Q3 2026 | $1K |
| Q3 2026 | $10 |
Quarter-by-quarter history
Every disclosed snapshot of the position
| Quarter | Value | Shares | % Portfolio | Change |
|---|---|---|---|---|
| Q3 2026 | $10 | 1 | — | — |
| Q3 2026 | $1K | 145 | — | — |
| Q3 2026 | $166K | 16.9K | — | — |
| Q3 2026 | $76K | 7.8K | — | — |
| Q2 2026 | $14 | 1 | — | — |
| Q2 2026 | $219K | 15.6K | — | — |
| Q2 2026 | $128K | 9.1K | — | — |
Other funds holding LYEL
$46.6M
$30.3M
$23.2M